|
Thursday, 21 December 2006 |
|
On February 11-13, 2007, the Parkinson's Action Network (PAN) will host the 2007 Research and Education & Public Policy Forum, the Louis Fishman Advocacy Awards Dinner in Washington, D.C., and a Congressional Reception on Capitol Hill. |
|
|
Tuesday, 19 December 2006 |
|
The following statement was made by Sean Tipton, president of the Coalition for the Advancement of Medical Research (CAMR) [PAN is a member organization of CAMR]: "Members of CAMR met today to discuss plans for stem cell legislation to be considered in the 110th Congress. We all agree that 2006 has been a memorable yet ultimately disappointing year in this battle for better treatments and cures. |
|
|
Monday, 27 November 2006 |
|
The Parkinson's Action Network (PAN) mourns the loss of Robert Kupperman after his long struggle with Parkinson's disease. He died Friday, November 24 at the age of 71. |
|
|
Monday, 13 November 2006 |
|
On Saturday, November 11, 2006, the Parkinson's Action Network (PAN) held its first-ever Midwest Regional Conference on Parkinson's disease, with the support of Schwarz Pharma. |
|
|
Thursday, 09 November 2006 |
|
Tuesday's election determined who will represent you when the new 110th Congress convenes in January of 2007. Leading up to the election, campaign news was dominated by the war in Iraq, immigration, economic and values issues. But in the last few weeks, Parkinson's disease and stem cell research, thanks to the work of so many advocates, played a prominent role in the political debates. So now it is time to think about what the election and the new 110th Congress means for the issues important to the Parkinson's community. |
|
|
Monday, 30 October 2006 |
|
The Parkinson's Action Network (PAN) is launching its first-ever regional conference, sponsored by Schwarz-Pharma, to educate the Parkinson's community about what it means to advocate for themselves, as well as to provide the resources to spread awareness important to the Parkinson's community. |
|
|
Friday, 27 October 2006 |
|
In the past few days, Parkinson’s disease and stem cell research have been discussed in the media and throughout the country at a level we have rarely seen. Although we at PAN do not involve ourselves in campaigns and candidates, we do involve ourselves with the one million Americans living with Parkinson’s disease. We stand with Michael J. Fox and the entire Parkinson’s community and are pleased that there has been so much awareness brought to the disease. |
|
|
Thursday, 26 October 2006 |
|
The Parkinson's Action Network (PAN) is launching its first-ever regional conference, sponsored by Schwarz-Pharma, to educate the Parkinson's community about what it means to advocate for themselves, as well as to provide the resources to spread awareness important to the Parkinson's community. |
|
|
Monday, 02 October 2006 |
On September 26, 2006, the Parkinson's Action Network hosted its 13th Annual Udall Awards Dinner. The dinner was a night of honoring PAN's advocates and the entire Parkinson's community for their hard work and support this past year in the mission to find better treatments and a cure for Parkinson's disease.
|
|
|
Thursday, 27 July 2006 |
|
Find out the latest news about PAN by reading our summer newsletter. PAN wants to keep you informed about the Parkinson’s community throughout the year. If you do not already receive our newsletter and email action alerts, please sign-up here. |
|
|
Tuesday, 18 July 2006 |
|
The Parkinson’s Action Network (PAN) on Tuesday applauded the overwhelming bipartisan passage of H.R. 810, the Stem Cell Research Enhancement Act, by a vote of 63-37. PAN now turns to President Bush and implores him to sign the legislation into law. |
|
|
Monday, 17 July 2006 |
|
Last week a senior White House aide suggested President Bush will likely veto legislation expanding federal funding of embryonic stem cell research. It would be unusually tragic if this became the president's first veto. |
|
|
Thursday, 29 June 2006 |
|
In a letter to Congress today, more than 40 organizations representing patients, health care providers, and advocates joined the American Physical Therapy Association (APTA) in urging members of Congress to extend the Medicare therapy cap exception process beyond 2006. |
|
|
Wednesday, 28 June 2006 |
|
Novartis Pharmaceuticals Corporation announced today that the U.S. Food and Drug Administration (FDA) has approved Exelon (rivastigmine tartrate) for the treatment of mild to moderate Parkinson’s disease dementia, making Exelon the first medication available for the treatment of this condition. |
|
|
Friday, 23 June 2006 |
|
Merck KGaA announced today the completion of two Phase III clinical trials of Sarizotan in advanced Parkinson’s disease patients suffering from dyskinesia. |
|
Powered by Phase2 Technology